I.G. Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$19.8M Sell
104,275
-42,700
-29% -$8.13M 0.1% 115
2017
Q2
$27.6M Buy
146,975
+12,479
+9% +$2.24M 0.14% 100
2017
Q1
$22.2M Sell
134,496
-254,998
-65% -$40.6M 0.11% 106
2016
Q4
$56M Sell
389,494
-601,642
-61% -$80.6M 0.29% 66
2016
Q3
$124M Buy
991,136
+961,636
+3,260% +$124M 0.48% 45
2016
Q2
$3.88M Buy
29,500
+3,771
+15% +$516K 0.02% 420
2016
Q1
$3.58M Buy
+25,729
New +$3.44M 0.01% 421
2015
Q1
Sell
-5,500
Closed -$691K 875
2014
Q4
$691K Hold
5,500
﹤0.01% 697
2014
Q3
$658K Buy
5,500
+1,100
+25% +$126K ﹤0.01% 661
2014
Q2
$473K Buy
4,400
+2,000
+83% +$206K ﹤0.01% 736
2014
Q1
$239K Sell
2,400
-900
-27% -$81.4K ﹤0.01% 765
2013
Q4
$305K Sell
3,300
-1,300
-28% -$116K ﹤0.01% 753
2013
Q3
$385K Sell
4,600
-400
-8% -$34.3K ﹤0.01% 728
2013
Q2
$409K Buy
+5,000
New +$374K ﹤0.01% 710

Other funds holding ELV

I.G. Investment Management's ELV Position: Q3 2017 in Review

I.G. Investment Management reduced its Elevance Health (ELV) stake by 29% in Q3 2017, selling an estimated $8.13M and leaving 104,275 shares worth $19.8M. The position accounts for 0.1% of the portfolio, ranked #115.

I.G. Investment Management first reported a position in ELV in Q2 2013 and has held it in 14 quarters since. The position peaked at $124M in Q3 2016. 845 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • I.G. Investment Management held 104,275 shares of Elevance Health worth $19.8M as of Q3 2017.
  • I.G. Investment Management sold 42,700 Elevance Health shares in Q3 2017, an estimated $8.13M.
  • Elevance Health made up 0.1% of I.G. Investment Management's portfolio in Q3 2017, its #115 holding.
  • I.G. Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 14 quarters since.
  • I.G. Investment Management's Elevance Health position peaked at $124M in Q3 2016.
  • 845 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.